Attributes | Values |
---|
rdf:type
| |
description
| - clinical trial (en)
- ensayo clínico (es)
- ensayu clínicu (ast)
- klinisch onderzoek (nl)
- клінічне випробування (uk)
- 临床试验 (zh)
|
rdfs:label
| - Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (en)
- Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (nl)
|
skos:prefLabel
| - Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (en)
- Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (nl)
|
name
| - Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (en)
- Dose Escalation of DF6002 in Patients With Advanced Solid Tumors, and Expansion in Selected Indications (nl)
|
title
| |
title
| - A Phase 1/2, First-In-Human, Multi-Part, Open-Label, Multiple-Ascending Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, Biological, and Clinical Activity of DF6002 as a Monotherapy and in Combination With Pembrolizumab in Patients With Locally Advanced or Metastatic Solid Tumors, and Expansion in Selected Indications (en)
|
end time
| |
end time
| |
instance of
| |
instance of
| |
start time
| |
start time
| |
country
| |
country
| |
main subject
| |
main subject
| |
research site
| |
research site
| |
research intervention
| |
research intervention
| |
minimum age
| |
minimum age
| |
medical condition
| |
medical condition
| |
number of participants
| |
number of participants
| |
study type
| |
study type
| |
ClinicalTrials.gov ID
| |
ClinicalTrials.gov ID
| |
clinical trial phase
| |
clinical trial phase
| |
research subject recruitment status
| |
research subject recruitment status
| |
is about
of | |